Scientists have reported that a single administration of psilocybin, the psychoactive compound in “magic mushrooms,” rapidly reversed both chronic pain and depressive-like symptoms in mice. Within just one day of treatment, the animals showed marked improvements in pain sensitivity and mood-related behavior, offering new insight into how psychedelics may influence brain circuits that link emotion and pain.
Targeting the Brain’s Emotional-Pain Network
The research found that psilocybin’s active metabolite, psilocin, exerted its strongest effects in the anterior cingulate cortex — a region that processes both emotional and physical distress. When psilocin was delivered to this brain area, abnormal nerve activity caused by chronic pain was normalized, and the animals’ hypersensitivity diminished. The study also highlighted the involvement of serotonin receptors 5-HT₂A and 5-HT₁A, suggesting these pathways are central to psilocybin’s ability to restore balance in disrupted brain networks.
A Potential Alternative to Traditional Pain Drugs
Researchers say the dual impact of psilocybin on mood and pain could pave the way for non-opioid treatments that address both dimensions of chronic pain. Unlike standard medications that act at the site of injury, the psychedelic compound appears to modulate higher-level brain systems that shape the experience of pain. While these findings are based on animal data, scientists believe they represent a promising step toward therapies capable of providing fast, lasting relief for patients with chronic pain and associated depression.
